StonvexLoading…
StonvexStonvexStonvexCore line items from BMNR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-02-28 | Q4 2025 2025-11-30 | Annual 2025 2025-08-31 | Q1 2025 2025-02-28 |
|---|---|---|---|---|
Revenue | $13.34M | $2.29M | $6.09M | $2.72M |
Operating Income | $-9.31B | $-5.47B | $444.21M | $-1.80M |
Net Income | $-9.02B | $-5.20B | $348.58M | $-2.13M |
EPS (Diluted) | $-23.17 | $-15.98 | $13.39 | $-2.34 |
Total Assets | $9.89B | $11.49B | $8.80B | $7.50M |
Total Liabilities | $36.17M | $235.74M | $102.26M | $4.65M |
Cash & Equivalents | $879.58M | $887.68M | $512.00M | $482.95K |
Free Cash Flow OCF − CapEx | $-316.98M | $-228.73M | $-5.21M | $-329.00K |
Shares Outstanding | 493.91M | 405.40M | 232.31M | 39.67M |